Braveheart Bio, Inc. insider trading
BRVE$21.27-0.14 (-0.65%)
“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.”
Insider Trading vs Stock Price
Insider Trading vs Stock Price data
Showing the 1Y range: Aug 6, 2026 to Oct 2, 2026. Price (-28.6%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.
| Date | Category | Person | Role | Action | Amount | Change in holding |
|---|
Open market purchase
Open market sellNet dollar flow · Buy / Sell balance
PremiumQ2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Unlock quarterly net flowKey players
- VAVineeta Agarwala11.3644%
- TMTravis Murdoch9.2556%
- JHJiangsu Hengrui Pharmaceuticals Co., Ltd.8.241%
- JVJason V. Coloma1.2222%
- DIDavid I. Malek1.1254%
- CVChristopher Viehbacher0.8439%
- JPJames Paul Rickey0.7814%
- MAMichele A. Anderson0.3689%
- ECErez Chimovits0.3036%
- DCDavid Charles Lubner0.0617%
AI Activity Analysis
PremiumComing soon
Insider activity
Fromto
| Company | Insider / role | Action | ΔOwn | Avg price | Amount | ||
|---|---|---|---|---|---|---|---|
| BRVE | AH Bio Fund IV, L.P. | Open market purchase$19.8M | +12.1% | $18.00 | $19.8M | Aug 7, 2026 | Aug 11, 2026 |
| BRVE | Erez Chimovits | Open market purchase$4.92M | Not reported | $18.00 | $4.92M | Aug 7, 2026 | Aug 11, 2026 |
| BRVE | Erez Chimovits | Open market purchase$30M | +16.3% | $18.00 | $30M | Aug 7, 2026 | Aug 11, 2026 |
| BRVE | Orbimed Advisors LLC | Open market purchase$4.92M | Not reported | $18.00 | $4.92M | Aug 7, 2026 | Aug 11, 2026 |
| BRVE | Orbimed Advisors LLC | Open market purchase$30M | +16.3% | $18.00 | $30M | Aug 7, 2026 | Aug 11, 2026 |
| BRVE | James Paul Rickey | Open market purchase$500K | +4.1% | $18.00 | $500K | Aug 7, 2026 | Aug 7, 2026 |
| BRVE | Christopher Viehbacher | Open market purchase$1.5M | +12.3% | $18.00 | $1.5M | Aug 7, 2026 | Aug 7, 2026 |
| BRVE | David I. Malek | Open market purchase$75K | +0.4% | $18.00 | $75K | Aug 7, 2026 | Aug 7, 2026 |
| BRVE | Michele A. Anderson | Open market purchase$20K | +0.3% | $18.00 | $20K | Aug 7, 2026 | Aug 7, 2026 |
| BRVE | Travis Murdoch | Open market purchase$1.5M | +1.0% | $18.00 | $1.5M | Aug 7, 2026 | Aug 7, 2026 |
| BRVE | David Charles Lubner | Open market purchase$1M | Not reported | $18.00 | $1M | Aug 7, 2026 | Aug 7, 2026 |
| BRVE | Forbion Growth Opportunities Fund III Cooperatief U.A. | Open market purchase$30.2M | +8.3% | $18.00 | $30.2M | Aug 7, 2026 | Aug 7, 2026 |
| BRVE | Forbion Growth Opportunities Fund III Cooperatief U.A. | Open market purchase$34.6M | +9.7% | $18.00 | $34.6M | Aug 7, 2026 | Aug 7, 2026 |